About Profex
Profex is a Healthcare company based in Shanghai (China) founded in 2001. Chinese Pharmaceutical Company. Profex has raised $15.5 million across 1 funding round from investors including Trident Capital and Mustang Ventures. Profex has completed 1 acquisition, including Korres. Its chief executive, as recorded, is Philip Xiao. Its focus areas include Traditional Pharmaceuticals. Its legal entity is Titan, Inc.
Company details
Profex is dermatology retail company that licenses, acquires, and markets proprietary and third-party products to the professional and consumer channels in China. Products include medicines, OTCs, aesthetic products and cosmeceuticals. The Company has two main divisions, professional and consumer. The professional division markets products to dermatologists, hospital and clinic environment. The consumer division sells and markets much of the same product portfolio to the direct-to-consumer channel with a concentration on retail pharmacies.
- Headquarters Shanghai, China
- SectorsHealthcare
- Website profex.com
- Social LinkedIn
- Legal Name Titan, Inc
- Total Equity Funding$15.5M (USD)
in 1 rounds
- Latest Funding Round$15.5M (USD), Series A
Aug 2008
- InvestorsTrident Capital
& 1 more
- Investments & Acquisitions
Funding Insights of Profex
Profex has successfully raised a total of $15.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $15.5 million completed in August 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.5M
- Total Rounds 1
- Last Round Series A — $15.5M
- First Round $15.5M
(Aug 2008)
- Investors Count 2
All 1 funding rounds of Profex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2008 | $15.5M | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Profex
Profex has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Trident Capital and Mustang Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Stage-agnostic investments in US ventures are made by Trident Capital. | tridentcap.com | Palo Alto, United States | ||
| mustangvc.com |
Investor details for Profex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Profex
5 people are tracked at Profex (4 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Philip Xiao | CEO | Leadership |
Luna Luo | Marketing Director | Leadership |
Karina Liao | Brand Director | Leadership |
Tianran Jiang | Vice President - Strategy & Corporate Development | Leadership |
Roland F. Bloomer | Owner | Team |
Complete people profiles for Profex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Profex
Profex has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Korres.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Natural beauty and personal care products are manufactured globally. | korres.com | Metamorfosi, Greece | 1996 | Dec 2017 | $58M |
Complete acquisition details for Profex
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Profex
3 dated milestones of Profex across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Profex is founded.
- Funding First funding round of $15.5M.
- Acquisition Acquires Korres.
Web traffic of Profex
The website of Profex (profex.com) receives about 2.5K visits a month.
- Monthly visits2.5K
▲ 33.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Profex
Profex was founded in 2001 and raised its 1st funding round 7 years after it was founded.
Profex is headquartered in Shanghai, China.
Philip Xiao is the CEO of Profex, as recorded in our data.
Profex is a funded company, having raised a total of $15.5M across 1 funding round to date. The company's 1st funding round was a Series A of $15.5M, raised on Aug 2008.
Profex is dermatology retail company that licenses, acquires, and markets proprietary and third-party products to the professional and consumer channels in China. Products include medicines, OTCs, aesthetic products and cosmeceuticals. The Company has two main divisions, professional and consumer. The professional division markets products to dermatologists, hospital and clinic environment. The consumer division sells and markets much of the same product portfolio to the direct-to-consumer channel with a concentration on retail pharmacies.
Profex has made 1 acquisition, including Korres.
Profex has 2 investors. Key investors include Trident Capital, and Mustang Ventures.
Profex operates through Titan, Inc.